`
`Considered the founder of the industry, Genentech, now a member of the Roche
`Group, has been delivering on the promise of biotechnology for over 35 years.
`
`At Genentech, we use human genetic information to discover, develop,
`manufacture and commercialize medicines to treat patients with serious or life
`threatening medical conditions. Today, we are among the world's leading biotech
`companies, with multiple products on the market and a promising development
`pipeline.
`
`Our Purpose
`
`Doing now what patients need next
`
`We believe it’s urgent to deliver medical solutions right now – even as we develop
`innovations for the future. We are passionate about transforming patients’ lives. We are
`courageous in both decision and action. And we believe that good business means a better
`world.
`
`That is why we come to work each day. We commit ourselves to scientific rigor, unassailable
`ethics, and access to medical innovations for all. We do this today to build a better
`tomorrow.
`
`We are proud of who we are, what we do, and how we do it. We are many, working as one
`across functions, across companies, and across the world.
`
`We are Roche.
`
`Our Values
`
`IMMUNOGEN 2200, pg. 1
`Phigenix v. Immunogen
`IPR2014-00676
`
`
`
`The three Roche values—Integrity, Courage, and Passion—are core to how we
`want to behave, as individuals and collectively as an organization.
`
`Passion means we use our drive and commitment to energize, engage and
`inspire others.
`
`Courage means we are entrepreneurial and thus take risks, reach beyond
`boundaries and experiment.
`
`Integrity means we are consistently open, honest, ethical and genuine.
`
`These values define fundamental attributes for guiding decisions and actions
`leading to increased innovation and business performance.
`
`A Member of the Roche Group
`
`Genentech became a member of the Roche Group in March of 2009. As part of their merger
`agreement, Roche and Genentech combined their pharmaceutical operations in the United
`States. Genentech's South San Francisco campus now serves as the headquarters for
`Roche pharmaceutical operations in the United States. Genentech Research and Early
`Development operates as an independent center within Roche.
`
`IMMUNOGEN 2200, pg. 2
`Phigenix v. Immunogen
`IPR2014-00676
`
`